Solara Active Pharma Sciences Limited — Others, 10-02-2025: Monitoring Agency Report

Solara Active Pharma Sciences Limited has shared the Monitoring Agency Report for the quarter ended December 31, 2024, regarding the utilization of proceeds from its Rights Issue worth ₹449.95 crore. Notably, the report indicates that all funds have been utilized according to the disclosures in the Offer Document, with ₹154.48 crore spent, primarily on repaying borrowings. There are no deviations or delays reported. This stability reinforces investor confidence in the company's capital management and strategic execution, suggesting a positive outlook for its financial health and operational strategies moving forward.